Palomino Laboratories Inc. financial data

Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 20.66 %
Debt-to-equity 63.34 %
Return On Equity -166 % -1.2%
Return On Assets -503 % -3.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,770,686 shares +2.8%
Common Stock, Shares, Outstanding 17,611,292 shares +2.5%
Entity Public Float 0 USD
Common Stock, Value, Issued 1,761 USD +2.5%
Weighted Average Number of Shares Outstanding, Basic 3,383,919 shares +1%
Weighted Average Number of Shares Outstanding, Diluted 3,383,919 shares +1%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 1,615,789 USD +12.8%
Operating Income (Loss) -1,615,789 USD -1,299.6%
Net Income (Loss) Attributable to Parent -2,430,552 USD -61.6%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares -17.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7,896,569 USD
Assets, Current 18,220 USD +46.9%
Assets 8,313 USD +24.8%
Accounts Payable, Current 60,952 USD
Liabilities, Current 999,013 USD +3.5%
Other Liabilities, Noncurrent 150,000 USD
Liabilities 999,013 USD +3.5%
Retained Earnings (Accumulated Deficit) -2,438,955 USD -10%
Stockholders' Equity Attributable to Parent 7,313,748 USD
Liabilities and Equity 8,313 USD +24.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10,960 USD
Common Stock, Shares Authorized 300,000,000 shares +5%
Common Stock, Shares, Issued 17,611,292 shares +2.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7,896,569 USD +55.3%
Deferred Tax Assets, Valuation Allowance 5,119 USD +16.8%
Deferred Tax Assets, Gross 5,119 USD +16.8%
Deferred Tax Assets, Operating Loss Carryforwards 2,406 USD +8.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital 9,750,942 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%